| RGGKX | RWIBX | RGGKX / RWIBX | |
| Total Expense Ratio | 1.10 | 1.51 | 73% |
| Annual Report Gross Expense Ratio | 1.49 | 1.51 | 99% |
| Fund Existence | 15 years | 24 years | - |
| Gain YTD | 11.998 | 15.289 | 78% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.99B | 152B | 1% |
| Annual Yield % from dividends | 0.36 | 0.74 | 49% |
| Returns for 1 year | 28.36 | 21.41 | 132% |
| Returns for 3 years | 74.07 | 50.98 | 145% |
| Returns for 5 years | 70.85 | 31.20 | 227% |
| Returns for 10 years | 264.00 | 92.57 | 285% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MLPD | 24.99 | 0.26 | +1.04% |
| Global X MLP & Engy Infras Cov Cll ETF | |||
| FCPI | 54.96 | 0.15 | +0.28% |
| Fidelity Stocks for Inflation ETF | |||
| DFGX | 53.24 | 0.07 | +0.13% |
| Dimensional International Cr Fxd Inc ETF | |||
| VGUS | 75.46 | N/A | N/A |
| Vanguard Ultra-Short Treasury ETF | |||
| BBC | 41.71 | -2.15 | -4.90% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||